(18)F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma

BACKGROUND: The methylation status of the O(6)-methylguanine-DNA methyltransferase (MGMT) promoter has emerged as a favorable independent prognostic and predictive biomarker in glioma. This study aimed to build a radiomics signature based on (18)F-fluorodeoxyglucose (FDG) positron emission tomograph...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Imaging
Asıl Yazarlar: Kong, Ziren, Lin, Yusong, Jiang, Chendan, Li, Longfei, Liu, Zehua, Wang, Yuekun, Dai, Congxin, Liu, Delin, Qin, Xuying, Wang, Yu, Liu, Zhenyu, Cheng, Xin, Tian, Jie, Ma, Wenbin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6701097/
https://ncbi.nlm.nih.gov/pubmed/31426864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40644-019-0246-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller